{
  "query": "eli lilly",
  "ticker": "LLY",
  "start_date": "01-01-2025",
  "end_date": "01-02-2025",
  "backward_start_date": "18-12-2024",
  "backward_end_date": "31-12-2024",
  "prediction_window_days": 31,
  "fetch_timestamp": "2026-02-06 05:28:21",
  "article_count": 11,
  "articles": [
    {
      "url": "https://seekingalpha.com/news/4391294-eli-lilly-among-best-big-pharma-2024-novo-among-worst",
      "url_mobile": "",
      "title": "Eli Lilly among best in Big Pharma in 2024 ; Novo among worst",
      "seendate": "20241228T144500Z",
      "socialimage": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2153927815/image_2153927815.jpg?io=getty-c-w750",
      "domain": "seekingalpha.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 4,
      "recency_weight": 1.0,
      "content": null,
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.4662
      },
      "impact_horizon_weight": 0.5161,
      "final_weight": 0.7097
    },
    {
      "url": "https://www.benzinga.com/trading-ideas/24/12/42561975/whos-next-to-join-tesla-broadcom-in-1-trillion-club-over-50-say-the-worlds-biggest-retailer",
      "url_mobile": "",
      "title": "Who Next To Join Tesla , Broadcom In $1 Trillion Club ? Over 50 % Say The World Biggest Retailer - Broadcom ( NASDAQ : AVGO ), JPMorgan Chase ( NYSE : JPM ) ",
      "seendate": "20241218T201500Z",
      "socialimage": "https://cdn.benzinga.com/files/images/story/2024/12/18/chart-investors-ai.png?&fit=crop",
      "domain": "benzinga.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 14,
      "recency_weight": 0.5,
      "content": "The results were as follows along with the market caps at the time the poll was conducted: Over half of readers polled said they believe Walmart will be the next company to join the $1 trillion club for the first time, followed by Eli Lilly at around one fourth of readers. The chart above shows that while Walmart is the top gainer year-to-date, it is Eli Lilly that has the better five-year stock growth. The results were: That poll was conducted when Eli Lilly and Taiwan Semiconductor both traded with market capitalizations of around $800 billion. Readers ended up being wrong with Eli Lilly still out of the club, while Taiwan Semiconductor, Tesla and Broadcom have all joined in recent months.",
      "content_stats": {
        "total_sentences": 30,
        "relevant_sentences": 4,
        "relevance_ratio": 0.13333333333333333,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "LONG_TERM",
        "horizon_days": 21,
        "confidence": 0.327
      },
      "impact_horizon_weight": 0.6129,
      "final_weight": 0.5677
    },
    {
      "url": "https://www.investopedia.com/top-stock-movers-now-broadcom-amd-resmed-and-more-8765845",
      "url_mobile": "",
      "title": "Top Stock Movers Now : Broadcom , AMD , ResMed , and More",
      "seendate": "20241223T210000Z",
      "socialimage": "https://www.investopedia.com/thmb/_e91aHwdjnw9qHn2JtwOeAfFwPE=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-19806700676-4876f91af7c24127be77dcdb15c28120.jpg",
      "domain": "investopedia.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 9,
      "recency_weight": 0.5,
      "content": "Shares of sleep apnea machine maker ResMed (RMD) slumped after theFood and Drug Administration (FDA)approved Eli Lilly’s (LLY) weight-loss treatment Zepbound totreat some sleep apnea patients. Eli Lilly shares climbed.",
      "content_stats": {
        "total_sentences": 18,
        "relevant_sentences": 2,
        "relevance_ratio": 0.1111111111111111,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "MEDIUM_TERM",
        "horizon_days": 10,
        "confidence": 0.4416
      },
      "impact_horizon_weight": 0.5161,
      "final_weight": 0.5097
    },
    {
      "url": "https://www.investopedia.com/dow-jones-today-12232024-8765703",
      "url_mobile": "",
      "title": "Dow Jones Today : Stocks Slip To Start Holiday - Shortened Week ; Honda Soars on Merger Plans",
      "seendate": "20241223T160000Z",
      "socialimage": "https://www.investopedia.com/thmb/TNTsdR0xPn0lQae59esdG8FGZQw=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/MarketBlogImage-final-6ac06c7b9250446a8e86c566b11e02e1.png",
      "domain": "investopedia.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 9,
      "recency_weight": 0.5,
      "content": "Eli Lilly (LLY) shares added nearly 4% after federal regulators approved its Zepbound weight-loss drug Zepbound to treat sleep apnea. Shares of sleep apnea machine maker ResMed (RMD) slumped after theFood and Drug Administration (FDA)approved Eli Lilly’s (LLY) weight-loss treatment Zepbound totreat some sleep apnea patients. Eli Lilly shares climbed. -Bill McColl Eli Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for Sleep Apnea Eli Lilly's (LLY) Zepbound has receivedFood and Drug Administration (FDA)approval as a treatment for obstructive sleep apnea for adults with obesity, the drugmaker announced late Friday. Zepbound got FDA approval to treat obesity and weight loss inNovember 2023, joining Eli Lilly's other tirzepatide-based drug, Mounjaro. Eli Lilly shares were up more than 2% in midday trading Monday, having gained about 34% on the year. Xerox to Acquire Lexmark. Eli Lilly.",
      "content_stats": {
        "total_sentences": 90,
        "relevant_sentences": 7,
        "relevance_ratio": 0.07777777777777778,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "MEDIUM_TERM",
        "horizon_days": 10,
        "confidence": 0.5554
      },
      "impact_horizon_weight": 0.5161,
      "final_weight": 0.5097
    },
    {
      "url": "https://www.investopedia.com/sandp-500-gains-and-losses-today-chip-stocks-surge-broadcom-amd-nvidia-8765818",
      "url_mobile": "",
      "title": "S & P 500 Gains and Losses Today : Chip Stocks Surge as Holiday Trading Week Begins",
      "seendate": "20241224T020000Z",
      "socialimage": "https://www.investopedia.com/thmb/6zY9Nw1Vxkrtr0LZqTOlpxEtPy4=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2189656773-518305a72e6c40d18af8a92063a5319b.jpg",
      "domain": "investopedia.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 8,
      "recency_weight": 0.5,
      "content": "Increased adoption of the blockbuster weight-loss drug from Eli Lilly (LLY) among sleep apnea patients could pressure sales of ResMed's continuous positive airway pressure, or CPAP, devices.Eli Lilly shares climbed 3.7%.",
      "content_stats": {
        "total_sentences": 25,
        "relevant_sentences": 1,
        "relevance_ratio": 0.04,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.4849
      },
      "impact_horizon_weight": 0.0669,
      "final_weight": 0.2402
    },
    {
      "url": "https://www.fxstreet.com/news/amgen-stock-gains-on-novonordisks-weightloss-drug-blunder-202412201846",
      "url_mobile": "https://www.fxstreet.com/amp/news/amgen-stock-gains-on-novonordisks-weightloss-drug-blunder-202412201846",
      "title": "Amgen stock gains on NovoNordisk weightloss drug blunder",
      "seendate": "20241223T091500Z",
      "socialimage": "https://editorial.fxstreet.com/images/Markets/Equities/Industries/Pharma/man-microscope-pharma_Large.jpg",
      "domain": "fxstreet.com",
      "language": "English",
      "sourcecountry": "China",
      "coverage_count": 1,
      "days_ago": 9,
      "recency_weight": 0.5,
      "content": "Eli Lilly’s (LLY)Zepbound already reduces weight among its users by 23%, according to similar testing.",
      "content_stats": {
        "total_sentences": 26,
        "relevant_sentences": 1,
        "relevance_ratio": 0.038461538461538464,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.3815
      },
      "impact_horizon_weight": 0.05,
      "final_weight": 0.23
    },
    {
      "url": "https://www.investors.com:443/news/technology/eli-lilly-weight-loss-drug-obstructive-sleep-apnea-resmed-cpap/",
      "url_mobile": "",
      "title": "Eli Lilly Weight - Loss Drug Wins Approval In Sleep Apnea ; Will ResMed Feel The Heat ? ",
      "seendate": "20241221T003000Z",
      "socialimage": "https://www.investors.com/wp-content/uploads/2024/09/Stock-EliLilly-building-04-shutt.jpg",
      "domain": "investors.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 11,
      "recency_weight": 0.5,
      "content": "Eli Lilly (LLY) gained Food and Drug Administration approval late Friday for its weight-loss drug, Zepbound, as a treatment for obstructive sleep apnea.",
      "content_stats": {
        "total_sentences": 5,
        "relevant_sentences": 1,
        "relevance_ratio": 0.2,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.6921
      },
      "impact_horizon_weight": 0.05,
      "final_weight": 0.23
    },
    {
      "url": "https://www.fool.com/investing/2024/12/20/novo-nordisk-destroyed-lilly-and-viking-stocks-up/?source=iedfolrf0000001",
      "url_mobile": "",
      "title": "Why Novo Nordisk Stock Got Destroyed Today , but Eli Lilly and Viking Stocks Are Up",
      "seendate": "20241220T174500Z",
      "socialimage": "https://g.foolcdn.com/editorial/images/801777/package-of-weight-loss-drug-next-to-a-barbell.jpg",
      "domain": "fool.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 12,
      "recency_weight": 0.5,
      "content": null,
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.4838
      },
      "impact_horizon_weight": 0.05,
      "final_weight": 0.23
    },
    {
      "url": "https://www.theglobeandmail.com/investing/markets/inside-the-market/article-market-movers-stocks-seeing-action-on-friday-december-20-and-why/",
      "url_mobile": "",
      "title": "Market movers : Stocks seeing action on Friday - and why",
      "seendate": "20241220T151500Z",
      "socialimage": "https://www.theglobeandmail.com/resizer/v2/MQVSCY5AZNECDMIRHE5JYMUSZM.JPG?auth=e538c83dcd0c2e016513c03088431c391028e6fa8141c28b2ad326514995a483&quality=80&smart=true",
      "domain": "theglobeandmail.com",
      "language": "English",
      "sourcecountry": "Canada",
      "coverage_count": 1,
      "days_ago": 12,
      "recency_weight": 0.5,
      "content": "The lower-than-expected weight loss from the drug candidate deals a blow to the Danish company’s ambitions for a successor to its Wegovy weight-loss drug that is more powerful than Eli Lilly’s (LLY-N) rival Zepbound, also known as Mounjaro.",
      "content_stats": {
        "total_sentences": 104,
        "relevant_sentences": 1,
        "relevance_ratio": 0.009615384615384616,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.5609
      },
      "impact_horizon_weight": 0.05,
      "final_weight": 0.23
    },
    {
      "url": "https://finance.yahoo.com/news/15-billion-reasons-love-eli-144500454.html",
      "url_mobile": "",
      "title": "15 Billion Reasons to Love Eli Lilly Stock Right Now",
      "seendate": "20241219T023000Z",
      "socialimage": "https://s.yimg.com/ny/api/res/1.2/gLXzfYLOrAUPS3ZIvs4H.g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/28363e4e6e66b90ea587e677d4ecf691",
      "domain": "finance.yahoo.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 13,
      "recency_weight": 0.5,
      "content": null,
      "content_stats": {
        "total_sentences": 5,
        "relevant_sentences": 0,
        "relevance_ratio": 0.0,
        "filtered": false,
        "filter_action": "no_match"
      },
      "impact_horizon": {
        "category": "SHORT_TERM",
        "horizon_days": 5,
        "confidence": 0.407
      },
      "impact_horizon_weight": 0.05,
      "final_weight": 0.23
    },
    {
      "url": "https://markets.businessinsider.com/news/stocks/eli-lilly-s-kisunla-approved-in-china-for-alzheimer-s-disease-treatment-1034148679",
      "url_mobile": "",
      "title": "Eli Lilly Kisunla approved in China for Alzheimer Disease treatment",
      "seendate": "20241218T061500Z",
      "socialimage": "",
      "domain": "markets.businessinsider.com",
      "language": "English",
      "sourcecountry": "United States",
      "coverage_count": 1,
      "days_ago": 14,
      "recency_weight": 0.5,
      "content": "The company states: “Eli Lilly (LLY) announced that the National Medical Products Administration in China has approved Kisunla, an Alzheimer’s treatment for adults with early symptomatic Alzheimer’s disease, which includes people with mild cognitive impairment, or MCI, as well as people with the mild dementia stage of Alzheimer’s disease who have confirmed amyloid pathology. In the TRAILBLAZER-ALZ 2 study, 66% of patients achieved plaque clearance at one year.” Published first onTheFly– the ultimate source for real-time, market-moving breaking financial news.Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on LLY: Copyright © 2026Insider Inc andfinanzen.netGmbH (Imprint).",
      "content_stats": {
        "total_sentences": 10,
        "relevant_sentences": 2,
        "relevance_ratio": 0.2,
        "filtered": true,
        "filter_action": "filtered"
      },
      "impact_horizon": {
        "category": "MEDIUM_TERM",
        "horizon_days": 10,
        "confidence": 0.3474
      },
      "impact_horizon_weight": 0.05,
      "final_weight": 0.23
    }
  ]
}